Actively Recruiting
Advanced Neuroimaging in Idiopathic Intracranial Hypertension
Led by Thomas Jefferson University · Updated on 2025-05-02
30
Participants Needed
1
Research Sites
43 weeks
Total Duration
On this page
Sponsors
T
Thomas Jefferson University
Lead Sponsor
A
American Headache Society
Collaborating Sponsor
AI-Summary
What this Trial Is About
Idiopathic intracranial hypertension (IIH) is characterized by elevated intracranial pressure leading to symptoms like papilledema, headache, and cognitive dysfunction. While the etiology is complex, abnormal cerebrospinal fluid dynamics due to venous outflow restriction from transverse sinus stenosis (TSS) is common. TSS may disrupt the glymphatic system, a brain-wide network facilitating cerebrospinal fluid and interstitial fluid exchange, by impairing CSF absorption, altering perivascular space dynamics, and disrupting pressure gradients crucial for waste clearance. Venous sinus stenting (VSS) can improve symptoms in many patients by alleviating venous congestion, but its effects on glymphatic function are unclear. This prospective study aims to evaluate novel quantitative brain imaging metrics as surrogate markers to better understand IIH pathophysiology before and after VSS in patients with refractory IIH and TSS. The investigators will use advanced MRI techniques, including MR elastography (MRE) to assess brain stiffness, diffusion tensor imaging (DTI) to evaluate water diffusion, arterial spin labeling (ASL) imaging to measure blood-brain barrier (BBB) permeability, and functional MRI to analyze pain networks. The investigators hypothesize that 1) these noninvasive imaging metrics will correlate with the degree of venous congestion and changes after venous sinus stenting (VSS) and 2) the imaging findings will correlate with clinical treatment outcomes. By correlating imaging markers with venous pressures and symptom changes, the investigators aim to gain insights into IIH mechanisms, expand diagnostic tools, and potentially guide clinical decision-making and treatment response monitoring. The overarching goal is to better understand IIH's underlying pathophysiology, which could lead to improved diagnostic criteria, more targeted treatments, and better prediction of treatment outcomes for patients with this challenging condition.
CONDITIONS
Official Title
Advanced Neuroimaging in Idiopathic Intracranial Hypertension
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with refractory idiopathic intracranial hypertension who require and plan to have venous sinus stenting
You will not qualify if you...
- History of head trauma or prior brain shunting or leak repair surgery
- Presence of major active non-head-related pain syndrome
- Any contraindications to undergoing MRI scans
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Jefferson Headache Center
Philadelphia, Pennsylvania, United States, 19107
Actively Recruiting
Research Team
E
Enchao Qiu, MD PhD
CONTACT
M
Mary Hopkins
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here